by Cancer Core Europe | Jul 20, 2020 | Cancer Core Europe
The increasing number and complexity of biomarkers that guide the selection of new therapies against cancer fragments knowledge on the biology of the disease and hinders the implementation of precision medicine. A new digital platform combines different cutting-edge...
by Cancer Core Europe | Apr 14, 2020 | Cancer Core Europe
Cancer Core Europe (CCE) have been forced by COVID-19 to adapt their approach to the treatment of patients with cancer. While still providing the same quality of care, of course. The specialist centres not only want to prevent the spread of the virus in general, but...
by Cancer Core Europe | Mar 16, 2019 | Cancer Core Europe
The increasing cancer burden is one of the leading medical societal challenges today. The number of new cancer patients in Europe is expected to increase from 3.6 (2015) to 4.3 million over the next two decades; it has now reached 3.91 million. Moreover, the number of...
by Cancer Core Europe | Mar 16, 2019 | Cancer Core Europe
Today, cancer is a significant challenge for society, healthcare systems and the growing number of affected patients and their families. This article argues that new paradigms and conditions for responsible science and innovation policy across the European Union (EU)...
by Cancer Core Europe | Mar 12, 2019 | Cancer Core Europe
Cancer treatment has made significant strides towards the promise of personalized medicine. Recent scientific advances have shown that there are numerous genetic deregulations that are common in multiple cancer types, raising the possibility of developing drugs...
